Does Early Childhood Vaccination Protect Against COVID-19?

Karzan R. Sidiq1,2, Dana Khdr Sabir2, Shakhawan M. Ali3, Rimantas Kodzius4,5
1Charmo Centre for Research, Training and Consultancy, Charmo University, Chamchamal, Iraq
2Department of Medical Laboratory Sciences, Charmo University, Chamchamal, Iraq
3Department of Oral and Maxillofacial Surgery, University of Sulaimani, Sulaimani, Iraq
4Faculty of Medicine, Ludwig Maximilian University of Munich (LMU), Munich, Germany
5Panevezys Faculty of Technology and Business, Kaunas Technology University (KTU), Panevezys, Lithuania

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ahmed, 2020, Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies, Viruses, 12, 254, 10.3390/v12030254

Anaya, 2013, Autoimmunity: From Bench to Bedside

Atabani, 1997, Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection, J. Virol, 71, 7240, 10.1128/JVI.71.10.7240-7245.1997

Bechini, 2013, Progress in the elimination of measles and congenital rubella in Central Italy, Hum. Vaccin. Immunother., 9, 649, 10.4161/hv.23261

Brodin, 2020, Why is COVID-19 so mild in children?, Acta Paediatr, 109, 1082, 10.1111/apa.15271

CarrozziG. SampaoloL. BolognesiL. BertozziN. FerranteG. MinardiV. Epidemia COVID-19. EpiCentro: L'epidemiologia per la sanità pubblica Istituto Superiore di Sanità2020

Cascella, 2020, “Features, evaluation and treatment coronavirus (COVID-19),”, StatPearls

2020, Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

China, 2020, Vital Surveillances: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020[J], The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team., 2, 113, 10.46234/ccdcw2020.032

Choe, 2012, Current status of measles in the Republic of Korea: an overview of case-based and seroepidemiological surveillance scheme, Korean J Pediatr., 55, 455, 10.3345/kjp.2012.55.12.455

Dai, 1991, Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China, Bull. World Health Organ., 69, 415

Dong, 2020, Epidemiology of COVID-19 among children in china, Pediatrics, 145, e20200702, 10.1542/peds.2020-0702

DuBois, 2013, Functional and evolutionary insight from the crystal structure of rubella virus protein E1, Nature, 493, 552, 10.1038/nature11741

2020, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, Zhonghua Liu Xing Bing Xue Za Zhi, 41, 145, 10.3760/cma.j.issn.0254-6450.2020.02.003

Frank, 2002, Immunology and Evolution of Infectious Diseases, 10.1515/9780691220161

Hashiguchi, 2018, Structures of the prefusion form of measles virus fusion protein in complex with inhibitors, Proc. Natl. Acad. Sci. U.S.A, 115, 2496, 10.1073/pnas.1718957115

Hoffmann, 2020, The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells, BioRxiv, 10.1101/2020.01.31.929042

Jacob, 2007, A tale of two tails: why are terminal residues of proteins exposed?, Bioinformatics, 23, e225, 10.1093/bioinformatics/btl318

Kontio, 2012, Waning antibody levels and avidity: implications for MMR vaccine-induced protection, J. Infect. Dis, 206, 1542, 10.1093/infdis/jis568

Updates on COVID-19 in Republic of Korea. Korean Centers for Disease Control & Prevention (KCDC)2020

Larsen, 2006, Improved method for predicting linear B-cell epitopes, Immun Res, 2, 2, 10.1186/1745-7580-2-2

Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8

Malvoisin, 1990, Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge, J. Virol, 64, 5160, 10.1128/JVI.64.10.5160-5162.1990

Montecillo-Aguado, 2019, Cross-reaction, enhancement, and neutralization activity of dengue virus antibodies against zika virus: a study in the Mexican population, J. Immunol. Res., 2019, 7239347, 10.1155/2019/7239347

Ponomarenko, 2007, Antibody-protein interactions: benchmark datasets and prediction tools evaluation, BMC Struct. Biol, 7, 64, 10.1186/1472-6807-7-64

Ralph, 2020, 2019-nCoV (Wuhan virus), a novel coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness, J. Infect. Dev. Ctries, 14, 3, 10.3855/jidc.12425

Remuzzi, 2020, COVID-19 and Italy: what next?, Lancet, 395, 1225, 10.1016/S0140-6736(20)30627-9

Sabir, 2020, Current speculations on the low incidence rate of the COVID-19 among children, Int. J. School. Health, 7, 37, 10.30476/intjsh.2020.85997.106

Thapa, 2019, The role of the thymus in the immune response, Thorac. Surg. Clin, 29, 123, 10.1016/j.thorsurg.2018.12.001

Wan, 2020, Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus, J. Virol, 94, e00127, 10.1128/JVI.00127-20

32421627Coronavirus Disease 2019 (COVID-19) Situation Report−103

, Coronavirus Disease 2019 (COVID-19): Situation.

Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507

Wu, 2020, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host Microbe, 27, 325, 10.1016/j.chom.2020.02.001

Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3

Xu, 2020, Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding, Nat. Med, 26, 1, 10.1038/s41591-020-0817-4

Zheng, 2018, The landscape of vaccines in China: history, classification, supply, and price, BMC Infect. Dis., 18, 502, 10.1186/s12879-018-3422-0